Indeed, despite numerous studies reporting on the loss of e-cadherin during EMT [18,19], Hollestelle et al. showed that the loss of e-cadherin is not a necessity for EMT in human breast cancer lines [20]. This evidence concerns the gene CDH1 and breast carcinoma.